🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I was very grateful to meet the former Swedish prime minister Ingvar Carlsson today. He told about his experiences in taking care of his wife with Alzheimer’s disease for the last decade. He is such a fantastic and kind person! And still going strong when 90 years old.

The BioFINDER group wishes you happy holidays!🎄

I agree. It was great fun and I learnt a lot!

Do you use CSF Ab42 or Ab42/40 as a biomarker for “Ab pathology” in Alzheimer's disease? Then I think this paper might be of interest to you. nature.com/articles/s4358…

🚨New paper published in Alzheimer's & Dementia Journals! alz-journals.onlinelibrary.wiley.com/doi/10.1002/al… PhD student Linda Karlsson et al. use machine learning (ML) to predict tau-PET composites from accessible and inexpensive modalities: plasma biomarkers, structural MRI and clinical variables. Details 👇

Finally, I would like to thank our incredible team including Carlos Cruchaga, Oskar Hansson, Nico Franzmeier, David Bennet, Henrik Zetterberg, Deniz Urey, Linda Karlsson, Zeyu Zhu, and the research participants who have made this work possible! Full study 🔗: nature.com/articles/s4159… 12/12

First panel of the DxA Day focuses on the current diagnostic landscape for Alzheimer’s - from development to implementation, featuring an expert panel les by Nicholas Ashton of Banner Health. CC Oskar Hansson, C2N Diagnostics, WashU Medicine, Beckman Coulter Life Sciences and Biogen

Great new study out in Nature Medicine identifies #Plasma eMTBR-tau243 as a specific #biomarker of #tau tangles in #Alzheimers disease, enabling the detecting and tracking of Alzheimer’s clinical impairment. #ADPD2025 nature.com/articles/s4159…

In a head-to-head comparison, plasma p-tau217 and tau-PET imaging equally predict which healthy people will develop mild cognitive impairment. Still, using both could streamline selection for clinical trials. Lund University Amsterdam UMC ow.ly/sp8h50VvgsI

We're entering a new era of #Alzheimers blood testing—fully automated platforms now deliver fast, accurate #pTau217 results for use in primary & secondary care. Proud to share senior authorship and proud of this multi-centre European collaboration. 🔗 nature.com/articles/s4159…

New manuscript alert! Can blood-based biomarkers measured on a fully automated platform accurately identify Alzheimer’s disease (AD) pathology?🩸 Our new multi-cohort study has now been published in Nature Medicine: nature.com/articles/s4159…. A thread🧵

p-Tau217 is a breakthrough blood test that can accurately predict and may help prevent Alzheimer's disease. erictopol.substack.com/p/the-breakthr… Here's the rundown on it. Free, open-access.

Plasma eMTBR-tau243 is a specific #biomarker of #tau tangles in #Alzheimer’s disease and enables the detecting and tracking of Alzheimer’s clinical impairment. #NeurodegenerativeDiseases #AlzheimersAwareness #Biomarkers nature.com/articles/s4159…

Fantastic work by Toomas Erik Anijärv 🇪🇪 et al! Not a bad first paper to have in the thesis! 🤩

Immunoassay choice for #pTau217 is important! In this study, we show that LMW #pTau217 is more specific to Alzheimers pathology than HMW #pTau217 immunoassay designs – which can give false-positives. alz-journals.onlinelibrary.wiley.com/doi/10.1002/al… BioFINDER Oskar Hansson

🚨New paper in Alzheimer's & Dementia! We investigate whether p-tau immuno-assays selectively quantifying low-molecular-weight (LMW) tau (CNS) are more specific for tau changes in AD vs ALS than assays not differentiating between LMW and high-MW (PNS) tau👇pmc.ncbi.nlm.nih.gov/articles/PMC12…

Individuals with more severe clinical Alzheimer disease symptoms than their biological stage often have additional pathologies. ja.ma/3H0b6TU